Simvastatin-romidepsin combination kills bladder cancer cells synergistically

The HMG-CoA reductase inhibitor simvastatin activates AMP-activated protein kinase (AMPK) and thereby induces histone acetylation. We postulated that combining simvastatin with the histone deacetylase (HDAC) inhibitor romidepsin would kill bladder cancer cells by inducing histone acetylation coopera...

Descripción completa

Detalles Bibliográficos
Autores principales: Okubo, Kazuki, Miyai, Kosuke, Kato, Kimi, Asano, Takako, Sato, Akinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220249/
https://www.ncbi.nlm.nih.gov/pubmed/34144348
http://dx.doi.org/10.1016/j.tranon.2021.101154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220249/
https://www.ncbi.nlm.nih.gov/pubmed/34144348
http://dx.doi.org/10.1016/j.tranon.2021.101154

Ejemplares similares